Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 8850 | 50.11 |
09:34 ET | 200 | 50.19 |
09:36 ET | 950 | 49.845 |
09:38 ET | 495 | 49.84 |
09:39 ET | 300 | 49.71 |
09:41 ET | 696 | 49.95 |
09:43 ET | 200 | 49.745 |
09:45 ET | 493 | 49.6 |
09:50 ET | 3281 | 49.13 |
09:52 ET | 200 | 49.25 |
09:54 ET | 100 | 49.2 |
09:56 ET | 358 | 49.155 |
09:57 ET | 350 | 49.2 |
09:59 ET | 500 | 49.3527 |
10:01 ET | 326 | 49.26 |
10:03 ET | 8600 | 49.23 |
10:06 ET | 5800 | 49.16 |
10:08 ET | 1473 | 49.215 |
10:12 ET | 500 | 49.22 |
10:14 ET | 710 | 49.11 |
10:15 ET | 3060 | 49.41 |
10:17 ET | 2810 | 49.33 |
10:19 ET | 200 | 49.285 |
10:21 ET | 600 | 49.14 |
10:24 ET | 2900 | 48.66 |
10:26 ET | 758 | 48.68 |
10:28 ET | 87074 | 48.49 |
10:30 ET | 2774 | 48.45 |
10:32 ET | 7678 | 48.45 |
10:33 ET | 2374 | 48.63 |
10:35 ET | 300 | 48.7 |
10:37 ET | 1800 | 48.79 |
10:39 ET | 7268 | 49.0609 |
10:42 ET | 600 | 49.16 |
10:44 ET | 1322 | 49.18 |
10:46 ET | 200 | 49.165 |
10:48 ET | 700 | 49.01 |
10:50 ET | 1749 | 48.99 |
10:53 ET | 1307 | 48.94 |
10:55 ET | 200 | 48.925 |
10:57 ET | 800 | 48.895 |
11:00 ET | 200 | 49.005 |
11:02 ET | 300 | 49.08 |
11:04 ET | 831 | 49.26 |
11:06 ET | 700 | 49.34 |
11:08 ET | 872 | 49.33 |
11:09 ET | 1751 | 49.215 |
11:11 ET | 360 | 49.28 |
11:13 ET | 300 | 49.205 |
11:15 ET | 100 | 49.205 |
11:18 ET | 402 | 49.27 |
11:20 ET | 800 | 49.31 |
11:22 ET | 300 | 49.26 |
11:24 ET | 370 | 49.315 |
11:26 ET | 3300 | 49.3075 |
11:27 ET | 100 | 49.34 |
11:29 ET | 100 | 49.36 |
11:31 ET | 800 | 49.28 |
11:33 ET | 1100 | 49.35 |
11:36 ET | 736 | 49.31 |
11:38 ET | 7708 | 49.26 |
11:40 ET | 200 | 49.235 |
11:42 ET | 200 | 49.215 |
11:44 ET | 1100 | 49.245 |
11:45 ET | 800 | 49.22 |
11:47 ET | 200 | 49.215 |
11:49 ET | 300 | 49.215 |
11:51 ET | 845 | 49.2 |
11:56 ET | 400 | 49.29 |
11:58 ET | 202 | 49.27 |
12:00 ET | 1298 | 49.085 |
12:02 ET | 600 | 49.18 |
12:03 ET | 200 | 49.185 |
12:05 ET | 300 | 49.19 |
12:07 ET | 710 | 49.2 |
12:09 ET | 700 | 49.15 |
12:12 ET | 200 | 49.055 |
12:16 ET | 200 | 49.0175 |
12:18 ET | 300 | 49.035 |
12:20 ET | 900 | 48.85 |
12:21 ET | 1787 | 48.695 |
12:25 ET | 1400 | 48.73 |
12:27 ET | 1440 | 48.61 |
12:30 ET | 600 | 48.4 |
12:32 ET | 600 | 48.44 |
12:34 ET | 500 | 48.495 |
12:36 ET | 2328 | 48.52 |
12:38 ET | 575 | 48.56 |
12:39 ET | 200 | 48.52 |
12:41 ET | 700 | 48.5 |
12:43 ET | 4005 | 48.485 |
12:45 ET | 720 | 48.485 |
12:48 ET | 37209 | 48.335 |
12:50 ET | 8644 | 48.5323 |
12:52 ET | 3428 | 48.555 |
12:54 ET | 1100 | 48.495 |
12:56 ET | 9100 | 48.6 |
12:57 ET | 1983 | 48.5255 |
12:59 ET | 592 | 48.485 |
01:01 ET | 7000 | 48.6 |
01:03 ET | 100 | 48.575 |
01:06 ET | 700 | 48.53 |
01:08 ET | 300 | 48.515 |
01:10 ET | 1400 | 48.345 |
01:12 ET | 3435 | 48.495 |
01:14 ET | 100 | 48.58 |
01:15 ET | 400 | 48.595 |
01:17 ET | 793 | 48.535 |
01:19 ET | 1200 | 48.5 |
01:21 ET | 400 | 48.495 |
01:26 ET | 150 | 48.52 |
01:30 ET | 2320 | 48.535 |
01:32 ET | 5636 | 48.495 |
01:33 ET | 2119 | 48.3 |
01:35 ET | 8782 | 48.4375 |
01:37 ET | 5283 | 48.465 |
01:39 ET | 5350 | 48.51 |
01:44 ET | 5823 | 48.345 |
01:46 ET | 591 | 48.36 |
01:48 ET | 100 | 48.36 |
01:50 ET | 100 | 48.3688 |
01:51 ET | 600 | 48.415 |
01:53 ET | 1263 | 48.415 |
01:55 ET | 2300 | 48.4 |
01:57 ET | 7332 | 48.02 |
02:00 ET | 1702 | 48.17 |
02:02 ET | 8119 | 48.2225 |
02:04 ET | 1800 | 48.155 |
02:06 ET | 2230 | 48.135 |
02:08 ET | 4100 | 48.17 |
02:09 ET | 1036 | 48.045 |
02:11 ET | 4780 | 48.02 |
02:13 ET | 1600 | 48.095 |
02:15 ET | 2549 | 48.21 |
02:18 ET | 2394 | 48.295 |
02:20 ET | 1670 | 48.34 |
02:22 ET | 2700 | 48.275 |
02:24 ET | 2970 | 48.27 |
02:26 ET | 2095 | 48.145 |
02:27 ET | 1000 | 48.29 |
02:29 ET | 700 | 48.33 |
02:31 ET | 1100 | 48.29 |
02:33 ET | 4310 | 48.32 |
02:36 ET | 1902 | 48.31 |
02:38 ET | 2715 | 48.32 |
02:40 ET | 1300 | 48.375 |
02:42 ET | 500 | 48.375 |
02:44 ET | 3099 | 48.23 |
02:45 ET | 8531 | 48.21 |
02:47 ET | 4180 | 48.23 |
02:49 ET | 3152 | 48.25 |
02:51 ET | 1100 | 48.2 |
02:54 ET | 2200 | 48.11 |
02:56 ET | 4304 | 48.07 |
02:58 ET | 1333 | 47.91 |
03:00 ET | 2993 | 47.985 |
03:02 ET | 3800 | 47.975 |
03:03 ET | 1500 | 47.95 |
03:05 ET | 1697 | 48.1 |
03:07 ET | 1800 | 48.08 |
03:09 ET | 900 | 48.12 |
03:12 ET | 500 | 47.98 |
03:14 ET | 1100 | 48.02 |
03:16 ET | 2070 | 47.9 |
03:18 ET | 4465 | 48.02 |
03:20 ET | 2145 | 48.02 |
03:21 ET | 1300 | 48.055 |
03:23 ET | 3200 | 48.145 |
03:25 ET | 1314 | 48.2 |
03:27 ET | 2136 | 48.325 |
03:30 ET | 1530 | 48.41 |
03:32 ET | 1570 | 48.26 |
03:34 ET | 3203 | 48.23 |
03:36 ET | 20229 | 48.41 |
03:38 ET | 2811 | 48.35 |
03:39 ET | 1812 | 48.52 |
03:41 ET | 4703 | 48.505 |
03:43 ET | 3700 | 48.59 |
03:45 ET | 1306 | 48.54 |
03:48 ET | 2005 | 48.4975 |
03:50 ET | 17309 | 48.48 |
03:52 ET | 4555 | 48.5 |
03:54 ET | 6219 | 48.58 |
03:56 ET | 14761 | 48.52 |
03:57 ET | 17479 | 48.6 |
03:59 ET | 48386 | 48.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.0B | -12.9x | --- |
Immunovant Inc | 4.3B | -15.6x | --- |
Nuvalent Inc | 4.5B | -27.7x | --- |
Biohaven Ltd | 3.4B | -5.3x | --- |
SpringWorks Therapeutics Inc | 3.3B | -8.3x | --- |
Alvotech SA | 4.2B | -6.6x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.9x |
Price/Sales (TTM) | 2,019.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.